---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-012981"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:46:18.399365+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Precigen grants PSUs tied to PRGN-2012 BLA milestones to named execs

## Summary
- Target PSUs granted: CEO Helen Sabzevari 1,650,000; CFO Harry Thomasian 250,000; COO Rutul Shah 250,000; CLO Donald Lehr 108,000.
- Vesting in two 50% installments upon: (1) FDA submission of BLA for PRGN-2012, (2) FDA approval of BLA, both by Dec 31, 2026.
- PSUs forfeited if milestones not achieved by end of Performance Period; vesting accelerated upon change in control in certain cases.
- Pro-rata vesting applies on termination without cause or for good reason; full forfeiture on other termination events.

## SEC filing metadata
- accession: 0000950103-24-012981
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000095010324012981/0000950103-24-012981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000095010324012981/dp217405_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-012981
- JSON: https://secwatch.observer/filing/0000950103-24-012981.json
- Plain text: https://secwatch.observer/filing/0000950103-24-012981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.